{"id":2856,"date":"2020-04-02T05:30:00","date_gmt":"2020-04-02T05:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/conference-call-on-interim-report-12\/"},"modified":"2020-04-02T05:30:00","modified_gmt":"2020-04-02T05:30:00","slug":"conference-call-on-interim-report-12","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/","title":{"rendered":"Conference call on Interim Report"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong>Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January &#8211; March 2020. The presentation will be held in English.<\/strong><\/div>\n<p><span><span>Time: Thursday, April 9, 2020 at 11.30 a.m. CET<\/span><\/span><\/p>\n<p><span><span>Information regarding the conference can be found under the following link:<br \/>\n<a href=\"https:\/\/event.on24.com\/wcc\/r\/2239698\/BC3013723908BBA313809D53E82CDF15\" rel=\"nofollow\"><span>https:\/\/event.on24.com\/wcc\/r\/2239698\/BC3013723908BBA313809D53E82CDF15<\/span><\/a><\/span><\/span><br \/>\n\u00a0<\/p>\n<p><span><span>Phone numbers to the conference:<br \/>\nSweden dial in number: +46\u00a0856\u00a0642 651<\/span><\/span><\/p>\n<p><span><span>USA dial in number: +1\u00a0631\u00a0913 1422<\/span><\/span><\/p>\n<p><span><span>International (UK) dial in number: +44 (0)3333 000\u00a0804<\/span><\/span><\/p>\n<p><span><span>Conference name: XVIVO Perfusion, Conference ID: 52504358#<\/span><\/span><br \/>\n\u00a0<\/p>\n<p><span><span>Participants from XVIVO Perfusion:<br \/>\nMagnus Nilsson, CEO<br \/>\nChristoffer Rosenblad, CFO<\/span><\/span><\/p>\n<p><span><span>The press release for XVIVO Perfusion\u2019s interim report January \u2013 March 2020 will be released on April 9, 2020 at 7:30 a.m. CET.<\/span><\/span><\/p>\n<p><span><span>Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com\/corporate\/.<\/span><\/span><\/p>\n<p><span><span>April 2, 2020<br \/>\nGothenburg<br \/>\nXVIVO Perfusion AB (publ)<\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><span>For further information please contact:<\/span><\/span><\/p>\n<p><span><span>Christoffer Rosenblad, CFO, +46 735 192159,\u00a0christoffer.rosenblad@xvivoperfusion.com<br \/>\n<span>Magnus Nilsson, CEO, +46 31-788 21 50, e-post: magnus.nilsson@xvivoperfusion<\/span>\u00a0<\/span><\/span><\/p>\n<p><span><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January &#8211; March 2020. The presentation&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2856","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-ci"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Conference call on Interim Report - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conference call on Interim Report - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January &#8211; March 2020. The presentation...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-12\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-12\\\/\",\"name\":\"Conference call on Interim Report - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2020-04-02T05:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-12\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-12\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-12\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conference call on Interim Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conference call on Interim Report - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/","og_locale":"en_US","og_type":"article","og_title":"Conference call on Interim Report - XVIVO","og_description":"Invitation to attend XVIVO Perfusion\u2019s conference call regarding the presentation of the interim report January &#8211; March 2020. The presentation...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/","name":"Conference call on Interim Report - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2020-04-02T05:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-12\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Conference call on Interim Report"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}